Churg-strauss syndrome in a group of patients receiving fluticasone for asthma.
Cooper
Sheldon M
SM
Rheumatology and Clinical Immunology Division, The University of Vermont College of Medicine, Burlington 05405, USA. scooper@zoo.uvm.edu
Libman
Bonita S
BS
Lazarovich
Mark
M
D000280:Administration, Inhalation; D000328:Adult; D000730:Androstadienes / Q000008:administration & dosage / Q000627:therapeutic use*; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001249:Asthma / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D015267:Churg-Strauss Syndrome / Q000150:complications* / Q000503:physiopathology; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D000068298:Fluticasone; D006801:Humans; D020024:Leukotriene Antagonists; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use
D000730:Androstadienes; D018927:Anti-Asthmatic Agents; D020024:Leukotriene Antagonists; D000068298:Fluticasone; D011241:Prednisone